Zantac 75 worldwide sales up 46% to $43 mil. in Warner-Lambert first quarter.
This article was originally published in The Tan Sheet
Executive Summary
ZANTAC 75 SALES UP 46% TO $43 MIL. WORLDWIDE in the first quarter, with sales of the H2 antagonist totaling $40 mil. in the U.S. and $3 mil. internationally (Canada and the U.K.), Warner-Lambert announced April 28. Revenues are likely to continue to push upward upon the launch of new Zantac Efferdose, approved by FDA Feb. 26 ("The Tan Sheet" March 2, p. 1).